Next Article in Journal
Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies
Next Article in Special Issue
Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma
Previous Article in Journal
Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors
Previous Article in Special Issue
Role of Lamin A/C as Candidate Biomarker of Aggressiveness and Tumorigenicity in Glioblastoma Multiforme
 
 
Article

Article Versions Notes

Biomedicines 2021, 9(10), 1498; https://doi.org/10.3390/biomedicines9101498
Action Date Notes Link
article pdf uploaded. 19 October 2021 17:00 CEST Version of Record https://www.mdpi.com/2227-9059/9/10/1498/pdf-vor
article supplementary file uploaded. 19 October 2021 17:00 CEST - https://www.mdpi.com/2227-9059/9/10/1498#supplementary
article xml file uploaded 21 October 2021 12:17 CEST Original file -
article xml uploaded. 21 October 2021 12:17 CEST Update https://www.mdpi.com/2227-9059/9/10/1498/xml
article pdf uploaded. 21 October 2021 12:17 CEST Updated version of record https://www.mdpi.com/2227-9059/9/10/1498/pdf
article html file updated 21 October 2021 12:19 CEST Original file -
article html file updated 30 July 2022 11:52 CEST Update https://www.mdpi.com/2227-9059/9/10/1498/html
Back to TopTop